Aryl aniline derivatives as beta2 adrenergic receptor agonists

Details for Australian Patent Application No. 2005206510 (hide)

Owner Theravance, Inc.

Inventors Jacobsen, John R.; Saito, Daisuke Roland; Trapp, Sean G.; McKinnell, Robert Murray

Agent Davies Collison Cave

Pub. Number AU-A-2005206510

PCT Pub. Number WO2005/070872

Priority 60/535,784 12.01.04 US

Filing date 11 January 2005

Wipo publication date 4 August 2005

International Classifications

C07C 215/60 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 233/43 (2006.01) Carboxylic acid amides

C07D 243/10 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070872 Priority application(s): WO2005/070872

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206511-Pyrimidyl phosphonate antiviral compounds and methods of use

2005206500-Composition comprising ethylene copolymers and polyolefin